Middle-molecule clearance at 20 and 35 ml/kg/h in continuous venovenous hemodiafiltration

Blood Purification

Volumn 29, Issue 3, 2010, Pages 259-263

  Hofmann, C L ^a   Fissell, W H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Acute injury; Continuous renal replacement therapy; Ficoll; Kidney dialysis; Middle molecules

Indexed keywords

FICOLL; FLUORESCEIN ISOTHIOCYANATE;

ARTICLE; CONTINUOUS HEMODIAFILTRATION; CONTROLLED STUDY; COW; DIALYSATE; IN VITRO STUDY; MACROMOLECULE; MIDDLE MOLECULE CLEARANCE; MOLECULAR PROBE; MOLECULAR WEIGHT; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; SIMULATION;

ANIMALS; CATTLE; HEMODIAFILTRATION; HUMANS; KIDNEY FAILURE, ACUTE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL REPLACEMENT THERAPY; TOXINS, BIOLOGICAL;

EID: 72049133466     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000266483     Document Type: Article

References (28)

1. VA/NIH Acute Renal Failure Trial Network: Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359: 7-20.
2. Bouman CS, et al: Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 2002; 30: 2205-2211.
3. Ronco C, et al: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000; 356: 26-30.
4. Saudan P, et al: Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 2006; 70: 1312-1317.
5. Tolwani AJ, et al: Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol 2008; 19: 1233-1238.
6. Lucchi L, et al: Clinical evaluation of internal hemodiafiltration (iHDF): a diffusive-convective technique performed with internal filtration enhanced high-flux dialyzers. Int J Artifi Organs 2004; 27: 414-419.
7. Padrini R, et al: Convective and adsorptive removal of beta2-microglobulin during predilutional and postdilutional hemofiltration. Kidney Int 2005; 68: 2331-2337.
8. Petras D, et al: Sequential convective therapies (SCT): a prospective study on feasibility, safety, adequacy and tolerance of on-line hemofiltration and hemodiafiltration in sequence. Int J Artif Organs 2005; 28: 482-488.
9. Randoux C, et al: Filtration of native and glycated beta2-microglobulin by charged and neutral dialysis membranes. Kidney Int 2001; 60: 1571-1577.
10. Santoro A, et al: Online convective therapies: results from a hemofiltration trial. Contrib Nephrol 2005; 149: 51-57.
11. Troyanov S, et al: Solute clearances during continuous venovenous haemofiltration at various ultrafiltration flow rates using Multiflow- 100 and HF1000 filters. Nephrol Dial Transplant 2003; 18: 961-966.
12. Wynckel A, et al: Improved removal of small proteins using continuous venovenous hemofiltration to treat acute renal failure. ASAIO J 2004; 50: 81-84.
13. Floege J, et al: Beta-2-microglobulin kinetics during haemofiltration. Nephrol Dial Transplant 1988; 3: 784-789.
14. Klinke B, et al: Transmembranous transport and adsorption of beta-2-microglobulin during hemodialysis using polysulfone, polyacrylonitrile, polymethylmethacrylate and cuprammonium rayon membranes. Int J Artif Organs 1989; 12: 697-702.
15. Messer J, Mulcahy B, Fissell WH: Middlemolecule clearance in CRRT: in-vitro convection, diffusion and dialyzer area. ASAIO J 2009; 55: 224-226.
16. Langsdorf LJ, Krankel LG, Zydney AL: Effect of blood-membrane interactions on solute clearance during hemodialysis. ASAIO J 1993; 39:M767-M772.
17. Langsdorf LJ, Zydney AL: Effect of blood contact on the transport properties of hemodialysis membranes: a two-layer membrane model. Blood Purif 1994; 12: 292-307.
18. Brunet S, et al: Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis 1999; 34: 486-492.
19. Ohlson M, Sorensson J, Haraldsson B: Glomerular size and charge selectivity in the rat as revealed by FITC-Ficoll and albumin. Am J Physiol Renal Physiol 2000; 279:F84-F91.
20. Paganini EP, et al: Prescription of adequate renal replacement in critically ill patients. Blood Purif 2001; 19: 238-244.
21. Boussekey N, et al: A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock. Intensive Care Med 2008; 34: 1646-1653.
22. Cornejo R, et al: High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock. Intensive Care Med 2006; 32: 713-722.
23. Delanaye P, et al: Confirmation of high cytokine clearance by hemofiltration with a cellulose triacetate membrane with large pores: an in vivo study. Int J Artif Organs 2006; 29: 944-948.
24. Haase M, et al: A pilot study of high-adsorption hemofiltration in human septic shock. Int J Artif Organs 2007; 30: 108-117.
25. Honore PM, et al: Blood and plasma treatments: the rationale of high-volume hemofiltration. Contrib Nephrol 2007; 156: 387-395.
26. Honore PM, et al: Blood and plasma treatments: high-volume hemofiltration - a global view. Contrib Nephrol 2007; 156: 371-386.
27. Lambermont B, et al: Large-pore membrane hemofiltration increases cytokine clearance and improves right ventricular-vascular coupling during endotoxic shock in pigs. Artif Organs 2006; 30: 560-564.
28. Rimmele T, et al: High-volume haemofiltration with a new haemofiltration membrane having enhanced adsorption properties in septic pigs. Nephrol Dial Transplant 2009; 24: 421-427.